tradingkey.logo
搜索

SANUWAVE Health Inc

SNWV
添加自选
4.550USD
+0.420+10.17%
收盘 09-18 16:00美东
38.93M总市值
2.35市盈率 TTM

关于 SANUWAVE Health Inc 公司

Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.

SANUWAVE Health Inc 简介

公司代码SNWV
公司名称SANUWAVE Health Inc
上市日期Nov 07, 2008
CEOFrank (Morgan C)
员工数量46
证券类型Ordinary Share
年结日Nov 07
公司地址9600 W. 6Th Sstreet
城市EDEN PRAIRIE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编55344
电话19526561029
网址https://sanuwave.com/
公司代码SNWV
上市日期Nov 07, 2008
CEOFrank (Morgan C)

SANUWAVE Health Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. James (Jim) Tyler
Mr. James (Jim) Tyler
Independent Director
Independent Director
8.70K
--
Mr. James (Jim) Tyler
Mr. James (Jim) Tyler
Independent Director
Independent Director
8.70K
--
Mr. Peter Stegagno
Mr. Peter Stegagno
Chief Regulatory Officer
Chief Regulatory Officer
2.03K
--
Mr. David Timothy (Tim) Wern
Mr. David Timothy (Tim) Wern
Executive Vice President - Sales, U.S. Wound Business
Executive Vice President - Sales, U.S. Wound Business
469.00
--
Mr. David Timothy (Tim) Wern
Mr. David Timothy (Tim) Wern
Executive Vice President - Sales, U.S. Wound Business
Executive Vice President - Sales, U.S. Wound Business
469.00
--
Dr. Iulian Cioanta, Ph.D.
Dr. Iulian Cioanta, Ph.D.
Chief Science and Technology Officer
Chief Science and Technology Officer
41.00
--
Mr. Daniel Coyle
Mr. Daniel Coyle
Chief Operating Officer
Chief Operating Officer
37.00
--
Mr. Daniel Coyle
Mr. Daniel Coyle
Chief Operating Officer
Chief Operating Officer
37.00
--
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
Independent Director
Independent Director
--
-100.00%
Mr. Ian Miller
Mr. Ian Miller
Lead Independent Director
Lead Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. James (Jim) Tyler
Mr. James (Jim) Tyler
Independent Director
Independent Director
8.70K
--
Mr. James (Jim) Tyler
Mr. James (Jim) Tyler
Independent Director
Independent Director
8.70K
--
Mr. Peter Stegagno
Mr. Peter Stegagno
Chief Regulatory Officer
Chief Regulatory Officer
2.03K
--
Mr. David Timothy (Tim) Wern
Mr. David Timothy (Tim) Wern
Executive Vice President - Sales, U.S. Wound Business
Executive Vice President - Sales, U.S. Wound Business
469.00
--
Mr. David Timothy (Tim) Wern
Mr. David Timothy (Tim) Wern
Executive Vice President - Sales, U.S. Wound Business
Executive Vice President - Sales, U.S. Wound Business
469.00
--
Dr. Iulian Cioanta, Ph.D.
Dr. Iulian Cioanta, Ph.D.
Chief Science and Technology Officer
Chief Science and Technology Officer
41.00
--

常见问题

SANUWAVE Health Inc的前五大股东是谁?

SANUWAVE Health Inc 的前五大股东如下:Mr. James (Jim) Tyler

有多少机构持有SANUWAVE Health Inc(SNWV)的股份?

截至2026Q1,共有125家机构持有SANUWAVE Health Inc的股份,合计持有的股份价值约为5.44M,占公司总股份的63.34%。与2025Q4相比,机构持股有所增加,增幅为562828.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有